Gelbart A, Thomas R
J Med Chem. 1978 Mar;21(3):284-8. doi: 10.1021/jm00201a010.
The synthesis, proof of structure, and biological activity of some new steroidal 17beta-formyl guanylhydrazones are described. The guanylhydrazones of nondigitalis-like steroids inhibited myocardial Na+,K+-ATPase but had only a depressant effect on myocardial contractility. By comparison, the corresponding guanylhydrazone of a digitalis-like steroid gave a positive inotropic effect in concentrations that also inhibited Na+,K+-ATPase. The nondigitalis-like guanylhydrazones also inhibited membrane Mg2+-ATPase and this may infer that the compounds act nonspecifically by membrane stabilization rather than by interaction with stereoselective receptors. Biological activity was determined in the guinea pig.
描述了一些新型甾体17β-甲酰基胍腙的合成、结构确证及生物活性。非洋地黄样甾体的胍腙抑制心肌Na⁺,K⁺-ATP酶,但对心肌收缩力仅有抑制作用。相比之下,洋地黄样甾体的相应胍腙在抑制Na⁺,K⁺-ATP酶的浓度下产生正性肌力作用。非洋地黄样胍腙也抑制膜Mg²⁺-ATP酶,这可能意味着这些化合物通过膜稳定作用而非与立体选择性受体相互作用产生非特异性作用。生物活性在豚鼠中测定。